铜绿假单胞菌
绿脓素
微生物学
群集运动
群体感应
生物膜
毒力
多粘菌素
抗生素
生物
多粘菌素B
细菌
药理学
佐剂
药物重新定位
突变体
抗菌剂
重新调整用途
秀丽隐杆线虫
化学
抗生素耐药性
作者
Jiawei Liu,Wei Jiang,Yang Yuan,Ziheng Zhang,Mengna Feng,Yiwen Chu,Xikun Zhou,Ting Huang,赵克蕾
标识
DOI:10.1093/jambio/lxag287
摘要
Aims The rapid emergence of multidrug-resistant Pseudomonas aeruginosa necessitates novel therapeutic strategies. This study aims to identify clinically approved drugs that can be repurposed as quorum sensing (QS) inhibitors to attenuate bacterial virulence and enhance antibiotic efficacy. Methods and Results Through virtual molecular docking against LasR, RhlR, and PqsR receptors, we identified chlorothiazide (CTZ) as a multi-target QS inhibitor. Phenotypic assays showed that CTZ significantly inhibited biofilm formation, pyocyanin production, extracellular protease activity, and motility in P. aeruginosa without affecting bacterial growth. Mechanistic studies using exogenous signal restoration, qPCR, and signal-deficient mutants confirmed that CTZ directly interferes with the Las, Rhl, and Pqs QS systems. CTZ also exhibited synergistic antibacterial activity with polymyxin B in vitro, reducing its MIC against multiple clinical isolates. In vivo, CTZ protected Caenorhabditis elegans from P. aeruginosa infection and, when combined with subtherapeutic polymyxin B, significantly improved survival and reduced bacterial load in a mouse acute pulmonary infection model. Conclusions CTZ functions as a promising anti-virulence adjuvant that potentiates conventional antibiotics, offering a dual strategy to improve treatment efficacy while mitigating resistance development.
科研通智能强力驱动
Strongly Powered by AbleSci AI